Sudeep Pharma Limited (NSE:SUDEEPPHRM)
1,207.60
-0.10 (-0.01%)
Nov 12, 2026, 3:29 PM IST
Sudeep Pharma Revenue
Sudeep Pharma had revenue of 1.97B INR in the quarter ending September 30, 2026, with 20.92% growth. This brings the company's total for the last twelve months to 7.10B, up 26.57% year-over-year. In the fiscal year ending March 31, 2026, Sudeep Pharma had annual revenue of 6.42B with 27.94% growth. That makes Sudeep Pharma the 24,872nd largest company in the world by revenue and 1,563rd in India.
Revenue (ttm)
7.10B
Revenue Growth
+26.57%
P/S Ratio
19.22
Revenue / Employee
13.52M
Employees
525
Market Cap
136.40B
Revenue by Segment
Fiscal year ended Mar 31, 2026 See the full Sudeep Pharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 6.42B | 1.40B | 27.94% |
| Mar 31, 2025 | 5.02B | 427.19M | 9.30% |
| Mar 31, 2024 | 4.59B | 305.42M | 7.12% |
| Mar 31, 2023 | 4.29B | 841.21M | 24.41% |
| Mar 31, 2022 | 3.45B | 3.38B | 4,999.06% |
| Mar 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2003 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Piramal Pharma | 97.79B |
| Alembic Pharmaceuticals | 84.77B |
| Strides Pharma Science | 52.13B |
| Akums Drugs and Pharmaceuticals | 48.29B |
| NATCO Pharma | 34.85B |
| Eris Lifesciences | 33.12B |
| Alivus Life Sciences | 26.84B |
| Cohance Lifesciences | 20.57B |
Sudeep Pharma News
- 14 days ago - Sudeep Pharma Transcript: Q2 26/27 - Transcripts
- 14 days ago - Sudeep Pharma Quarterly report: Q2 2027 - Filings
- 14 days ago - Sudeep Pharma Slides: Q2 2027 - Filings
- 3 months ago - Sudeep Pharma Quarterly report: Q1 2027 - Filings
- 3 months ago - Sudeep Pharma Slides: Q1 2027 - Filings
- 5 months ago - Sudeep Pharma Quarterly report: Q4 2026 - Filings
- 5 months ago - Sudeep Pharma Slides: Q4 2026 - Filings
- 5 months ago - Sudeep Pharma Annual report: Q4 2026 - Filings